blood test

Stable14 articles12 sourcesDernière mise à jour: 22/07/2026

Sujets associésprostate cancer early detection cancer screening fetal DNA amniocentesis Broad Institute PSA test ovarian cancer

Derniers articles

Unapproved Ovarian Cancer Blood Test Available in Australia Sparks Expert Concern

En développement

Santé·22/07/2026Résumé IA

Unapproved Ovarian Cancer Blood Test Available in Australia Sparks Expert Concern

An "early detection blood test" for ovarian cancer is now available in Australia for $1,495, marketed by BCAL Diagnostics. Despite ads targeting all women, the company states it's for high-risk individuals. Experts warn the test is not TGA-approved, has limited data, and a significant false-positive rate, potentially causing distress and unnecessary costs.

Guardian Australia

4 min de lecture

Alzheimer's blood test can detect disease 20 years before symptoms

En développement

Santé·05/07/2026Résumé IA

Alzheimer's blood test can detect disease 20 years before symptoms

Ett nytt blodprov som mäter alzheimermarkören p-tau217 kan upptäcka sjukdomen upp till 20 år före symtom. Testet används inom specialistsjukvården men rekommenderas inte för oroliga individer. Privata kliniker erbjuder testet, vilket oroar experter som menar att metoden missbrukas och att det saknas tydliga riktlinjer för positiva resultat.

Dagens Nyheter

2 min de lecture

Freddy the Fan: The World Cup's Viral Enigma and America's Online Legend

En développement

Culture·05/07/2026Résumé IA

Freddy the Fan: The World Cup's Viral Enigma and America's Online Legend

Freddy, a German fan who gained viral fame on social media during the World Cup, has disappeared from X after facing scrutiny over his authenticity. While some saw him as a genuine tourist, others suspected a marketing ploy. His online presence, now mainly on Instagram, continues to fuel debate about reality vs. performance in the digital age.

Guardian Sport

6 min de lecture

Hong Kong Researchers Developing Affordable Blood Test for Prostate Cancer

En développement

Santé·21/06/2026Résumé IA

Hong Kong Researchers Developing Affordable Blood Test for Prostate Cancer

Hong Kong researchers are developing an affordable blood test for prostate cancer, aiming to reduce the need for invasive biopsies. The technology is expected to launch in about two years, offering a less uncomfortable diagnostic process for patients like Peter Wan, who experienced a lengthy and invasive journey to his diagnosis.

SCMP Economy

1 min de lecture

New Blood Test Can Screen Thousands of Fetal Genetic Diseases

En développement

Santé·13/06/2026Résumé IA

New Blood Test Can Screen Thousands of Fetal Genetic Diseases

A new non-invasive prenatal test (NIPT) called NIFS can screen for thousands of severe genetic diseases by analyzing fetal DNA from maternal blood, with over 97% accuracy. Developed by researchers from the Broad Institute, this technology promises to reduce reliance on invasive procedures like amniocentesis, though concerns about over-screening and parental anxiety have been raised.

Santé·13/06/2026Résumé IA

New Maternal Blood Test Detects Thousands of Fetal Genetic Conditions

Scientists have developed a new non-invasive maternal blood test, NIFS, capable of detecting thousands of serious genetic conditions in a fetus. This advanced sequencing technique identifies fetal DNA fragments in the mother's blood, potentially replacing invasive procedures like amniocentesis and offering earlier diagnosis for a wider range of disorders.

Guardian International

3 min de lecture

UK expands prostate cancer trial for black men

En développement

Santé·02/06/2026Résumé IA

UK expands prostate cancer trial for black men

Tens of thousands more black men aged 45-74 in the UK will be invited for prostate cancer checks as part of an £18 million government-funded trial. The move aims to find better testing methods for the disease, which disproportionately affects black men.

MiraOne: Bridging the Gap Between Data and Actionable Wellness

MiraOne, a comprehensive blood test founded by Dr. Nickhil Jakatdar, Dr. Nickhil Phadke, and Mr. Abhinav Kejriwal, combines blood markers, genetic insights, and medicine-response analysis into a single report. It aims to provide personalized and actionable wellness recommendations, addressing the limitations of traditional medicine and empowering individuals to make informed health decisions.

MiraOne Comprehensive Blood Test Launched in Mumbai

MiraOne, a comprehensive blood test, launched in Mumbai, provides a single report integrating blood markers, DNA analysis, and pharmacogenomics to offer personalized health insights, aiming to transform India's healthcare approach.

Times of India

2 min de lecture

Swimmer Andriy Govorov Explains First-Time Drug Use for Enhanced Games

En développement

Sport·23/05/2026Résumé IA

Swimmer Andriy Govorov Explains First-Time Drug Use for Enhanced Games

Ukrainian swimmer Andriy Govorov details his first experience with performance-enhancing drugs for the controversial Enhanced Games in Las Vegas, where athletes use banned substances for financial rewards. The event faces strong opposition from anti-doping agencies.

Guardian Sport

5 min de lecture

New Blood Test Could Detect Alzheimer's Decades Earlier

En développement

Santé·22/05/2026Résumé IA

New Blood Test Could Detect Alzheimer's Decades Earlier

Researchers believe a simple blood test measuring pTau181 protein, combined with memory complaints, can detect Alzheimer's up to 30 years before diagnosis. This early detection could allow for preventative lifestyle changes or treatments to slow disease progression.

Hematologist advises blood test for anxiety

Hematologist Rodolfo Cameo stated that people with high anxiety should get a vitamin B12 test, as a deficiency can mimic anxiety symptoms and lead to depression, dementia, and psychosis.

Prostate Cancer Screening Reduces Deaths but Has Small Absolute Benefit and Risks

A comprehensive review of six trials with nearly 800,000 men shows prostate cancer screening reduces deaths by 2 per 1,000 men screened, but also leads to unnecessary treatments and complications, highlighting the need for informed patient decisions.

Guardian UK

4 min de lecture

The Threat of Anthropic’s 'Claude Mythos': A New Era of AI-Powered Cyber-Attacks

Urgent

Tech·13/04/2026Résumé IA

The Threat of Anthropic’s 'Claude Mythos': A New Era of AI-Powered Cyber-Attacks

Anthropic has unveiled 'Claude Mythos', an AI model with advanced cybersecurity and hacking capabilities. While being shared with tech giants to patch vulnerabilities, the model's potential for misuse and the lack of regulation raise alarms about global digital infrastructure security.

Guardian Business

3 min de lecture